4//SEC Filing
Ruth Matthew R. 4
Accession 0001385508-22-000114
CIK 0001385508other
Filed
Jul 20, 8:00 PM ET
Accepted
Jul 21, 4:08 PM ET
Size
5.3 KB
Accession
0001385508-22-000114
Insider Transaction Report
Form 4
Ruth Matthew R.
Chief Commercial Officer
Transactions
- Sale
Common Stock
2022-07-20$10.62/sh−1,084$11,512→ 29,916 total
Footnotes (2)
- [F1]These shares were sold to cover tax withholding obligations in connection with the vesting of restricted stock units.
- [F2]This transaction was executed in multiple trades at prices ranging from $10.34 to $10.75. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
OPIANT PHARMACEUTICALS, INC.
CIK 0001385508
Entity typeother
Related Parties
1- filerCIK 0001872022
Filing Metadata
- Form type
- 4
- Filed
- Jul 20, 8:00 PM ET
- Accepted
- Jul 21, 4:08 PM ET
- Size
- 5.3 KB